Ready to unlock the full potential of cannabinoid-based therapies? As an end-to-end partner, we can help enhance the odds of therapeutic breakthroughs and streamline development pathways in the cannabinoids space.
We offer a unique innovation platform powered by our leading-edge technical capabilities, clinical study proficiency, and robust cannabidiol (CBD) API offering elevated by Verilege™. This suite of expert services and superior customer care is designed to help you navigate the market with confidence and peace of mind.
Together, we can unlock new treatment possibilities for patients worldwide.
What if there was a therapeutic compound that could transform healthcare as we know it? We believe cannabidiol (CBD) holds that potential. Emerging clinical evidence reveals the significant promise of CBD in numerous health indications—driving increased research investment and creating rich opportunities to unravel the many potential therapeutic applications of this molecule.
CBtru® is an innovative, formulated CBD drug product intermediate and patent-pending solution that is designed to overcome bioavailability challenges, optimizing patient convenience and compliance.
Offering comparable bioavailability to the only market-approved CBD drug product (which is in a liquid oil-based form), CBtru® enables the development of oral solid dosage forms with higher API loading. This innovative solution is making more patient-friendly therapies—such as capsules, tablets, and more—possible in the CBD space.
CBD and other cannabinoids hold great therapeutic promise. But currently available drug delivery formats face challenges, like API absorption. Learn how to optimize CBD bioavailability.
What’s next in cannabinoid-based R&D and product innovation? Find out in this on-demand Future Scientific Horizons panel discussion from ICBC Berlin 2024.
What’s the difference between naturally sourced and synthetic cannabinoids? Or why is bioavailability a key consideration? Get the answers to common questions and bust misconceptions about CBD for pharma applications.
Discover how dsm-firmenich is tackling the challenge of bitter medicine with a receptor-based technology designed to elevate drug palatability and improve patient adherence.
Explore how dsm-firmenich can help pharma raise the bar in patient-centricity and sustainability.
Discover the top 5 trends transforming pharma regulations in Asia-Pacific and how drug developers can navigate this evolving landscape with dsm-firmenich.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.
